Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11525 posts found.

Imlygic

European approval for Amgen cancer drug Imlygic

December 18, 2015 Sales and Marketing Amgen, European Commission, Imlygic, melanoma, skin cancer, t-vec, talimogene laherparepvec

The European Commission has approved the use of Amgen’s Imlygic for adults with advanced melanoma, making it the first drug …
News
shkreli_youtube_screenshot

Karma may have caught up with Martin Shkreli, but America’s drug pricing problem isn’t about one man

December 18, 2015 Manufacturing and Production, Sales and Marketing Daraprim, Martin Shkreli, Turing Pharmaceuticals

As so often occurs in situations of this kind, Twitter reacted with a significant amount of glee and schadenfreude to …
Feature
ceo_arnaud_lallouette

Servier UK appoints new chief executive

December 18, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Arnaud Lallouette, Mike Sumpter, Servier

Dr Arnaud Lallouette has been appointed chief executive of Servier Laboratories, the UK subsidiary of the French-based pharma firm, after …
Appointment
tim-walbert

Horizon chief exec Walbert to head up US biotech trade body

December 18, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Illinois Biotechnology Industry Organisation, Timothy Walbert, iBio, illinois

Timothy Walbert, the chairman, president and chief executive of Horizon Pharma, has been elected as chairman of the board of …
Appointment
landing-hero-images1

ViiV Healthcare to acquire Bristol-Myers Squibb’s HIV pipeline drugs

December 18, 2015 Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, HIV, ViiV, ViiV Healthcare

Specialist HIV company ViiV Healthcare has agreed deals worth up to $1.46 billion to purchase Bristol-Myers Squibb’s late stage HIV …
News
Alliance Pharma logo

Alliance Pharma buys Sinclair’s healthcare products business for £132m

December 17, 2015 Manufacturing and Production, Sales and Marketing Alliance Pharma, Sinclair IS Pharma, acquisitions, dermatology merger

Alliance has completed a £132 million purchase of Sinclair IS Pharma’s non-aesthetics healthcare business as it moves to strengthen its …
News
FDA sign

FDA approves Lilly/Boehringer Lantus biosimilar

December 17, 2015 Medical Communications, Sales and Marketing Basaglar, Boehringer Ingelheim, Eli Lilly, Lantus, Sanofi, abasaglar, biosimilar, diabetes, insulin, lilly

The FDA has approved Eli Lilly and Boehringer Ingelheim’s long-acting insulin Basaglar (insulin glargine injection – a biosimilar to rival Sanofi’s …
News
Shkreli KaloBios

Turing chief exec Martin Shkreli arrested

December 17, 2015 Medical Communications, Sales and Marketing Daraprim, FBI, Martin Shkreli, Shkreli, turing

Turing chief executive Martin Shkreli has been arrested on a charge of securities fraud relating to a company he founded, …
News

AstraZeneca to buy majority share in Acerta Pharma

December 17, 2015 Sales and Marketing Acerta Pharma, AstraZeneca, acalabrutinib, acquisitions, mergers

Following several days of speculation, AstraZeneca has announced that it has agreed a deal to buy Acerta Pharma, a developer …
News
kelner_rob_070427

Valeant hires attorney and crisis management firm to handle bad US PR

December 17, 2015 Medical Communications, Sales and Marketing Robert Kelner, Valeant, Vianovo. Covington & Burling

Valeant has retained attorney Robert Kelner, a partner at the law firm Covington & Burling, to help the beleaguered pharma …
Appointment

New final NICE guidance on AbbVie, BMS, Pfizer and Roche drugs

December 16, 2015 Sales and Marketing BioMarin Pharma, Enbrel, Humira, Ikervis, MPS IVa, NICE, NICE guidance, Orencia, RoActemra, Santen, apremilast, ciclosporin, dry eye syndrome, juvenile idiopathic arthritis, otezla, psoriatic arthritis, vimizin

NICE has published final guidance on several drugs, approving therapies for juvenile idiopathic arthritis, dry eye disease and Morquio A …
News
Return on investment

Analysts say pharma R&D returns challenged by drag of high costs

December 16, 2015 Research and Development, Sales and Marketing R&D, drug development, research and development, return of investment, sales, sales forecasts

The projected rate of return on pharma industry research and development has more than halved since 2010, from 10.1% to …
News
NHS sign

NICE rejects BMS cancer drug in draft guidance

December 16, 2015 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, NHS, NICE, lung cancer, nivolumab, non small cell lung cancer, non-small cell lung cancer, opdivo

In draft guidance, NICE has chosen not to recommend Bristol-Myers Squibb’s Opdivo for the treatment of locally advanced or metastatic …
News
Kadcyla

NICE says no to NHS funding for Kadcyla

December 16, 2015 Research and Development, Sales and Marketing Breast Cancer Now, Kadcyla, NHS, NICE, Roche, advanced breast cancer, breast cancer

NICE has turned down Roche’s application for NHS funding for Kadcyla as a treatment for a type of advanced breast …
News
amgen_hq

Amgen buys back rights to three drugs from GSK

December 15, 2015 Research and Development, Sales and Marketing Amgen, GSK

Amgen has announced that it will reacquire the rights to three products in 48 countries from GSK, as it seeks …
News
The Gateway to Local Adoption Series

Latest content

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026

Abselion appoints Dale Gordon as Chair

March 30, 2026

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026